0001225208-13-008589.txt : 20130328
0001225208-13-008589.hdr.sgml : 20130328
20130328163115
ACCESSION NUMBER: 0001225208-13-008589
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130326
FILED AS OF DATE: 20130328
DATE AS OF CHANGE: 20130328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CORNELIUS JAMES M
CENTRAL INDEX KEY: 0001198959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01136
FILM NUMBER: 13724404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO
CENTRAL INDEX KEY: 0000014272
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 220790350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
BUSINESS PHONE: 2125464000
MAIL ADDRESS:
STREET 1: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
FORMER COMPANY:
FORMER CONFORMED NAME: BRISTOL MYERS CO
DATE OF NAME CHANGE: 19891012
4
1
doc4.xml
X0306
4
2013-03-26
0000014272
BRISTOL MYERS SQUIBB CO
BMY
0001198959
CORNELIUS JAMES M
BRISTOL-MYERS SQUIBB COMPANY
345 PARK AVENUE
NEW YORK
NY
10154
1
Common Stock, $0.10 par value
2013-03-26
4
S
0
10000.0000
40.6200
D
891218.0000
D
Common Stock, $0.10 par value
2013-03-27
4
S
0
10000.0000
40.6800
D
881218.0000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2012.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $40.39 to $40.71, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $40.39 to $40.82, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
/s/ Katherine R. Kelly, attorney-in-fact for James M. Cornelius
2013-03-28